We have read with great interest the work published recently by Kårhus et al. (1) where they describe the efficacy of the glucagon-like peptide-1 (GLP-1) agonist Liraglutide in two patients diagnosed with severe bile acid malabsorption (BAM) by causing a complete remission of symptoms.
